It's the first FDA attempt to directly police online platforms like Hims, which have long argued they're not subject to traditional drug advertising rules. The FDA also posted separate warning letters to manufacturers of the so-called GLP-1 drugs, taking issue with a 2024 infomercial featuring Oprah Winfrey. Regulators said the 42-minute TV segment from Eli Lilly and Novo Nordisk gave a "misleading impression" about the safety of Zepbound, Wegovy and similar "drugs with multiple serious, potentially life-threatening risks." Health Secretary Robert F. Kennedy Jr. has long been a critic of the pharmaceutical industry, including GLP-1 drugs, and previously suggested Americans can reverse obesity with diet and exercise alone. A memo signed by President Donald Trump last week directed Kennedy and the FDA to ensure that pharmaceutical ads on TV, social media and other websites are "truthful and non-misleading."